Hyun S Kim

6430445, Aug 6, 2002

Nov 13, 2000

09/710652

Hyun Jong Kim - Los Angeles CA, 90010
Ki Suk Kim - Los Angeles CA, 90010

A61F 200

607100, 607 2, 600 13

An anti-aging device to control the level of oxidation occurring at skin surface is described. The device is plugged into an electrical outlet to allow electromagnetic waves to pass through the inner surface, which has been pre-treated with far infrared light. The resulting affect on the skin is the reduced appearance of wrinkles and other signs of aging.

D490875, Jun 1, 2004

Dec 3, 2002

29/171904

Hyun Jong Kim - Los Angeles CA, 90010

2301

D23207, D7378

6783664, Aug 31, 2004

Nov 27, 2002

10/307049

Hyun Jong Kim - Los Angeles CA, 90010

C02F 148

210 85, 210 94, 210222, 210223, 366142

A water-treating device having a water jar, a magnetic agitator, an additive container having a bottom plate and a sleeve attached to the bottom plate, and an agitator driver that rotates the magnetic driver. The sleeve of the additive container has an outer wall, an inner wall, and mineral particles filled between the inner wall and the outer wall. The magnetic agitator has a base and a Y-shaped fin that protrudes upward from the base. The magnetic agitator has a magnetic bar between the fin and the base. The base has a shape of a disc having an upper surface and a lower surface, wherein the lower surface is convex. A metal plate is attached to the lower surface. The bottom plate also has a metal plate that contacts the metal plate of the base.

7189392, Mar 13, 2007

Oct 13, 2000

09/687281

Hyun Kim - Middleton MA, US
Rebecca Li - Bedford MA, US
Alessandra Pavesio - Padua, IT
Lanfranco Callegaro - Thiene, IT
Howard Seeherman - Cambridge MA, US
John Wozney - Hudson MA, US

Genetics Institute, LLC - Cambridge MA
Fidia Advanced Biopolymers S.R.L. - Abano Terme

A61K 38/43

424 941

An injectable formulation is disclosed for delivery of osteogenic proteins. The formulation comprises a pharmaceutically acceptable admixture of an osteogenic protein; and formulations comprising osteogenic protein, hyaluronic acid derivatives and tricalcium phosphate are also disclosed. Methods for formulating porous injectable gels and pastes from hyaluronic acid are also disclosed.

7304398, Dec 4, 2007

May 30, 2006

11/442200

Hyun Bong Kim - Northridge CA, US
Yong Ja Kim - Northridge CA, US
Michelle Lee - Northridge CA, US
Sung Ki Kim - Northridge CA, US
Jung Ki Kim - Northridge CA, US

F03B 13/10
F03B 13/12
H02P 9/04
F02B 63/04
F02B 67/04

290 1E, 290 42, 290 53

A spring activated energy transducer is provided. The energy transducer of the current invention generates alternating current (A/C) electricity from abundant external natural forces. The energy transducer is comprised of an upper part and a lower part. The upper part is comprised of a housing, a helix metal spring, a first circular board, a second circular board, pluralities of permanent magnets embedded to the second circular board, a third circular board with pluralities of permanent magnets facing the permanent magnets embedded in the second circular board with same magnetic pole, an upper metal shaft welded to the third circular board, four arc-shaped springs welded to the third circular board, and four wheel sets rotatably attached to one end of the spring. The lower part is comprised of a housing, a lower metal shaft, a fourth circular board placed on the upper end of the lower part, bundles of electric wire, pluralities of permanent magnets, and a fifth circular board placed at the lower end of the lower part. As the helix metal spring is compressed by an external force, the bundle of electric wire turns between permanent magnets to produce electricity.

7476984, Jan 13, 2009

May 26, 2006

11/441288

Hyun Bong Kim - Northridge CA, US
Yong Ja Kim - Northridge CA, US
Michelle Lee - Northridge CA, US
Sung Ki Kim - Northridge CA, US
Jung Ki Kim - Northridge CA, US

F03B 13/10

290 1E

The energy transducer includes an upper part and a lower part. The upper part having a housing, a helix metal spring, a first circular board, a second circular board with a short metal shaft, a ball bearing engaged to the short metal shaft, a third circular board with a groove to receive metal bearing balls, an upper metal shaft welded to the bottom of the third circular board, four arc-shaped springs welded to the bottom of the third circular board, and four sets of wheels rotatably attached to one end of the spring. The lower part includes: a housing, a lower metal shaft, a fourth circular board placed on the upper end of the lower part, bundles of electric wire, pluralities of permanent magnets, and a fifth circular board placed at the lower end of the lower part. As the helix metal spring is compressed by an external force, the bundle of electric wire turns between permanent magnets to produce electricity. Direction of the electricity alternates as the helix metal spring oscillates.

7608580, Oct 27, 2009

Jan 18, 2007

11/624463

Hyun Kim - Middleton MA, US
Rebecca Li - Bedford MA, US
Alessandra Pavesio - Padua, IT
Lanfranco Callegaro - Thiene, IT
Howard Seeherman - Cambridge MA, US
John Wozney - Hudson MA, US

Genetics Institute, LLC - Cambridge MA
Fidia Advanced Biopolymers S.R.L. - Abano Terme, Padua

A61K 38/16

514 2

An injectable formulation is disclosed for delivery of osteogenic proteins. The formulation comprises a pharmaceutically acceptable admixture of an osteogenic protein; and formulations comprising osteogenic protein, hyaluronic acid derivatives and tricalcium phosphate are also disclosed. Methods for formulating porous injectable gels and pastes from hyaluronic acid are also disclosed.

7771755, Aug 10, 2010

Sep 10, 2004

10/937364

Rebecca Li - Bedford MA, US
Howard Seeherman - Cambridge MA, US
Hyun Kim - Bedford MA, US

Wyeth - Madison NJ
Etex Corporation - Cambridge MA

A61K 38/23
A61K 33/42

424602, 424499, 514 12, 530350

Osteogenic proteins are delivered via an injectable solid rod or hardenable paste. The formulation comprises a calcium phosphate material, an osteogenic protein, and optional additives and active ingredients such as a bone resorption inhibitor. Methods of making injectable pharmaceutical compositions and methods of using the osteogenic compositions to treat bone defects are also disclosed.